Deal-hun­gry Ver­i­ly se­cures $1B in fresh fund­ing, months af­ter press­ing pause on smart lens project

Rough­ly two years af­ter procur­ing its first out­side in­vest­ment, Ver­i­ly — the pro­lif­ic deal-mak­ing life sci­ences unit of Al­pha­bet — has se­cured $1 bil­lion in fresh funds led by Sil­ver Lake.

As the lines be­tween health­care and tech­nol­o­gy blur, the unit — for­mer­ly known as Google Life Sci­ences — is de­vel­op­ing tools to col­late and or­ga­nize health da­ta, and uti­lize this da­ta with its part­ners to bet­ter de­vel­op drugs and de­vices as well as in­form ther­a­peu­tic adop­tion. The mon­ey will be used to fu­el Ver­i­ly’s vo­ra­cious ap­petite for deals, part­ner­ships and ac­qui­si­tions. The com­pa­ny, which counts for­mer FDA com­mis­sion­er Robert Califf as an ad­vis­er, al­ready has a laun­dry list of al­liances in its ar­se­nal.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER